TOKYO — Japan's Kirin Holdings has secured enough shares to take over supplement maker Fancl, its new president said, overcoming rival buying by an overseas fund and furthering the beermaker's transition into health care.Takeshi Minakata, who rose to the top role in the company in March, said he wanted to declare victory when Kirin's tender offer was due to close on Wednesday, but financial regulations forced an extension to September 11 after Hong Kong-based MY.
'We are naturally aiming for companies with a certain level of unique technology, products and brands,' he said. 'In that sense, North America is a big market that is still growing significantly. I think it has great potential.'Minakata joined Kirin in 1984, two years after the company leveraged its fermentation know-how to make its first foray into the pharma sector.